Literature DB >> 3624222

The secondary structure of bacteriorhodopsin determined by Raman and circular dichroism spectroscopy.

H Vogel, W Gärtner.   

Abstract

The secondary structure of bacterio-opsin (BO), the retinal free protein-component of bacteriorhodopsin (BR), has been determined by Raman spectroscopy. Additional circular dichroism (CD) measurements have revealed only negligible conformational differences between BO in apomembranes and BR in purple membranes. Therefore, the secondary structure of BR was derived from the Raman data of BO. The protein conformation was determined to consist of 72-82% helices, 2-11% beta-strands, and 11-17% beta-turns. Only about half of the helical structures correspond to alpha 1-helices, the other half possess non-alpha 1-helical structures. According to the analysis of the Raman data, the derived secondary structure of BR was obtained with high reliability for all structure classes which can be distinguished by this method within the given uncertainty range. This is a remarkable difference from recently published secondary structural data derived from CD measurements where the helix content was reported to be between 50 and 80%. The inherent experimental and methodological uncertainties of the CD-technique leading to such a range of variation are critically discussed in comparison to the method of Raman spectroscopy. The combined application of Raman and CD spectroscopy, as performed here, is demonstrated to be a substantial improvement in the secondary structure determination of retinal-containing membrane proteins. On the basis of our results, some of the recently proposed structural models of BR with a beta-strand content of more than 11% can be ruled out.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624222

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The effect of protein conformation change from alpha(II) to alpha(I) on the bacteriorhodopsin photocycle.

Authors:  J Wang; M A El-Sayed
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

2.  Temperature jump-induced secondary structural change of the membrane protein bacteriorhodopsin in the premelting temperature region: a nanosecond time-resolved Fourier transform infrared study.

Authors:  J Wang; M A El-Sayed
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

3.  Fourier transform infrared study of the effect of different cations on bacteriorhodopsin protein thermal stability.

Authors:  Colin D Heyes; Jianping Wang; Laurie S Sanii; Mostafa A El-Sayed
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

4.  Evidence for unbenignant nature of glucose as a replacement for water in purple membranes.

Authors:  N J Gibson; J Y Cassim
Journal:  Biophys J       Date:  1993-05       Impact factor: 4.033

5.  Dramatic in situ conformational dynamics of the transmembrane protein bacteriorhodopsin.

Authors:  J E Draheim; N J Gibson; J Y Cassim
Journal:  Biophys J       Date:  1991-07       Impact factor: 4.033

6.  Observations concerning topology and locations of helix ends of membrane proteins of known structure.

Authors:  S H White; R E Jacobs
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

7.  Analysis of conformational changes in bacteriorhodopsin upon retinal removal.

Authors:  J Cladera; J Torres; E Padrós
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

8.  Formation of stable polypeptide monolayers at interfaces: controlling molecular conformation and orientation.

Authors:  M Boncheva; H Vogel
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

9.  Spectroscopic studies of bacteriorhodopsin fragments dissolved in organic solution.

Authors:  J Torres; E Padrós
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

10.  Infrared dichroism of amide I and amide II modes of alpha I- and alpha II-helix segments in membrane proteins.

Authors:  W C Reisdorf; S Krimm
Journal:  Biophys J       Date:  1995-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.